Valuation Soars 45x Over Eight Years — Mabgeek Biotech’s High-Stakes IPO Ahead of Critical Phase III Trials
Valuation Soars 45x Over Eight Years — Mabgeek Biotech’s High-Stakes IPO Ahead of Critical Phase III Trials